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Aim: To present practical examples of our new algorithm for reconstruction of 3D dose
distribution, based on the actual MLC leaf movement.
Background: DynaLog and RTplan ﬁles were used by DDcon software to prepare a new RTplan
ﬁle  for dose distribution reconstruction.
Materials and methods: Four different clinically relevant scenarios were used to assess the fea-
sibility of the proposed new approach: (1) Reconstruction of whole treatment sessions for
prostate cancer; (2) Reconstruction of IMRT veriﬁcation treatment plan; (3) Dose reconstruc-
tion  in breast cancer; (4) Reconstruction of interrupted arc and complementary plan for an
interrupted VMAT treatment session of prostate cancer. The applied reconstruction method
was  validated by comparing reconstructed and measured ﬂuence maps. For all statistical
analysis, the U Mann–Whitney test was used.
Results: In the ﬁrst two and the fourth cases, there were no statistically signiﬁcant differ-
ences between the planned and reconstructed dose distribution (p = 0.910, p = 0.975, p = 0.893,
respectively). In the third case the differences were statistically signiﬁcant (p = 0.015). Treat-
ment  plan had to be reconstructed.
Conclusion: Developed dose distribution reconstruction algorithm presents a very useful QAtool.  It provides means for 3D dose distribution veriﬁcation in patient volume and allows to
evaluate the inﬂuence of actual MLC leaf motion on the dose distribution.
©  2014 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.∗ Corresponding author at: Radiotherapy Department, MSC Memorial 
Gliwice,  Wybrzez˙e Armii Krajowej 15, Poland. Tel.: +48 32 278 80 40.
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.  Background
odern radiotherapy takes advantage of the latest devel-
pments in technology and informatics to calculate and
xecute radiation dose distributions according to the high-
st therapeutic requirements. The radiation dose delivered
o the tumor volume should be big enough to destroy can-
er cells, while not causing permanent damage to normal
issues. Combination of: (i) multileaf collimators, (ii) accelera-
or gantry rotation, (iii) dose rate modulation while the beam
s on, (iv) precise dose calculation algorithms, and (v) faster
omputers allows to maximize the therapeutic ratio. One of
he tasks of the medical physicist is to verify whether the
lanned radiation dose is delivered in agreement with previ-
usly made calculations. Veriﬁcation of the radiation dose and
ts distribution for dynamic treatment techniques presents a
ather difﬁcult problem. Although these techniques have been
pplied for several years, an optimal process of quality assur-
nce (QA) needs to be established.1,2 In clinical practice, QA
ethods for in vivo dosimetry for static, CRT (e.g. CRT – Con-
ormal Radio Therapy) techniques, where the shape of the
eam does not change continuously during the irradiation,
re not suitable for dynamic treatment techniques.3 Currently,
he most common veriﬁcation method of the calculated dose
istribution for dynamic treatment techniques are ﬂuence
aps and in-phantom dose distribution measurements before
reatment.4 These measurements utilize: (i) water-equivalent
hantom with ionization chamber, (ii) matrix of ionization
hambers, or (iii) matrix of semiconductor dosimeters. For
xample, the latter can be part of an accelerator (e.g. EPID –
lectronic Portal Imaging Device, VMS  – Varian Medical Sys-
ems). Of course, the measurements are made in phantom
nd do not involve patient. Using an EPID device and Varian
reatment Planning System (TPS) there is possibility to mea-
ure ﬂuence maps and compare them with those previously
alculated by TPS. For evaluation of the difference between
alculated and measured values, gamma index is commonly
sed. As it is rather difﬁcult to deﬁne globally acceptable
iscrepancies between planned and measured ﬂuence maps,
ach center must develop its individual standards. Then, one
as to identify the proper solution and ﬁnd out where the
ifference between the planned and measured ﬂuence maps
xceeds the acceptable level. It is known that the accuracy of a
uence map  might be affected by many  parameters, including
ose rate5 and the optimizing indices value. If the discrepancy
etween planned and measured ﬂuence maps is unaccept-
ble, a new treatment plan must be prepared.6,7 At the Maria
kłodowska-Curie Memorial Cancer Center and Institute of
ncology in Gliwice, IMRT  (Intensity Modulated Radiation
herapy) and VMAT  (Volumetric Modulated Arc Therapy) tech-
iques have been used in clinical practice since 2000 and 2009,
espectively. Our experience shows that re-planning is a very
ime-consuming procedure, which often does not produce the
esired results. Therefore, there is a pressing need for other
ethods to verify compliance of the planned and realized dose
istributions. We  postulate that data stored in DynaLog ﬁles
ould be used to reconstruct dose distribution not only in the
hantom,8 but also in patient’s body after every treatment
raction. Varian log ﬁles are generated by Multileaf Collimatortherapy 1 9 ( 2 0 1 4 ) 420–427 421
(MLC) controller during the performance of dynamic treat-
ment technique.
2.  Aim
The aim of the work was to present practical examples of our
new algorithm for 3D dose distribution reconstruction based
on the actual MLC leaf movement.
3.  Materials  and  methods
TPS Eclipse 10 VMS was used for all dose distribution calcula-
tions. All measurements were carried out using Varian Clinac
23 EX with Millenium 120 collimator and OBI (e.g. OBI – On-
Board Imager) system.
Following is the description of the applied procedures. Dur-
ing the treatment session, for every single ﬁeld (IMRT) or arc
(VMAT) MLC controller generates two DynaLog ﬁles in ASCI
format for each MLC bank separately. The DynaLog data are
taken every 50 ms.  The stored information includes: fraction
dose, tolerance, beam on state, beam hold-off state, gantry
and collimator rotation, jaws positions, and the position of
each leaf.9 During the optimization of dynamic treatment
plan, optimal ﬂuence maps are calculated to simulate dif-
ferent beamlet intensity of the ﬁeld. After completing the
optimization process, the system generates DVHs (Dose Vol-
ume  Histograms – dependence graphs of dose and structure
volume) that describe optimal dose distribution. However,
oftentimes it is impossible to generate optimal ﬂuence maps
on an accelerator and it is necessary to recalculate the leaf
movement  and convert them to actual ﬂuence maps, which
are the basis for 3D dose calculations. Therefore, DVHs gen-
erated after calculation of 3D dose distribution differ from
the previously accepted ones during the optimization process.
Actual ﬂuence maps are different from optimal ones because
they consider mechanical limitations of MLC. The differences
may increase if the differences between values of the opti-
mization indices are grater or the discrepancies between point
doses placed close from each other differ signiﬁcantly.10,11 The
ﬁnal treatment plan is stored in the database as RTplan DICOM
ﬁle to allow its execution on the accelerator. The stored RTplan
ﬁle contains patient personal data, treatment plan data, infor-
mation about every ﬁeld or arc, including leaf position, gantry
angle, dose rate, dose, etc. The leaf movement  during the
treatment is continuous but since the system cannot store all
leaf positions in RTplan ﬁle, all leaf positions are stored in a
discrete manner as control points. During the treatment real-
ization, MLC controller linearly interpolates positions between
those control points. The new idea of dose reconstruction
is very simple. If the DynaLog ﬁles collected during therapy
are available and RTplan ﬁle can be exported from the treat-
ment planning system, it is possible to create a new RTplan
ﬁle by changing the planned leaf positions and the gantry
position (only for VMAT) in the RTplan ﬁle using the data col-
lected in DynaLog ﬁles. New RTplan DICOM ﬁle can be then
imported back to TPS. After obtaining (recalculating) a new
(reconstructed) plan, the system will generate a correspond-
ing 3D dose distribution but, this time, it will be the real dose
distribution delivered for patient during treatment session.
422  reports of practical oncology and radiotherapy 1 9 ( 2 0 1 4 ) 420–427
COMFig. 1 – (A) A part of RTplan DI
Thereby, we  can assess the real reconstruction of delivered
dose distribution, which can be compared with theoretical one
in TPS.The ﬁrst step in the reconstruction algorithm was to deal
with DynaLog ﬁles. According to Varian documentation,9 the
MLC  controller stores DynaLog data in a temporary buffer.
Fig. 2 – The theoretical (left side) and reconstructed (right side) d
technique. Dose reconstruction was made for 38 treatment fracti
rectum (orange) and bladder (blue). The differences between the 
margin of calculation error. ﬁle, (B) a part of DynaLog ﬁle.
Each loading a new dynamic treatment, the MLC  controller
overwrites the DynaLog data from the previous treatment.
So, for a ﬁnished treatment, the DynaLog data are no longer
available. To prevent these data from being lost, the auto-save
option must be turned on to save all DynaLog ﬁles. Because
of the limited disk space on the local station, all ﬁles have to
ose distribution for treatment plan prepared for the VMAT
ons. The DVH graphs show dose distributions for PTV (red),
theoretical and reconstructed dose distributions are in the
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Fig. 3 – An example of the evaluation of the measured (right side) and planned (left side) ﬂuence maps comparison. Gamma
index is less than one in 84.8% of the analyzed points of the treatment ﬁeld. It means that the evaluation is negative and
measurement should be repeated. If re-measurement is not satisfactory, then the plan will have to be re-optimized and the
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e transferred from the local station to another one having a
reater disk capacity. To perform this operation, synchronized
oftware was used.
In the second step, we used Delphi v 5.0 programming lan-
uage to develop special software, called DDcon, to convert
ynaLog ﬁles to RTplan DICOM ﬁle accepted by TPS Eclipse v
0. Fig. 1 shows examples of RTplan DICOM ﬁle and DynaLog
le.
DDcon software generates a new RTplan ﬁle by changing
he planned leaf positions and the gantry position (only for
MAT) in a RTplan ﬁle by the data collected in DynaLog ﬁles.
hen, a new RTplan DICOM ﬁle can be imported back to TPS.
fter recalculating a new (reconstructed) plan, the system will
enerate 3D dose distributions delivered to the patient during
he treatment session.
To compare the reconstructed plan with the calculated
ose distribution, DVHs and RPI factor (Radiation Planning
ndex)12 were used. RPI is a formula used to compare differ-
nt treatment plans for one patient. It takes in to account
he relation between dose distribution calculated for plan-
ing treatment volumes and organs at risk. The comparison
f theoretical ﬂuence maps to those generated during recon-
truction was performed to assess the level of treatment
recision. To evaluate the compared ﬂuence maps, gamma
ndex was used (3% and 2 mm).  To verify correct operation of
he reconstruction algorithm, ﬂuence maps from the recon-
tructed plan were compared with the measured ones. For this
ig. 4 – Planned (left side) and reconstructed (right side) dose dis
dark blue), spinal canal (cyan), and brainstem (brown) are withinpurpose, we developed a veriﬁcation algorithm involving the
following steps: (1) creating a treatment plan (dose distribu-
tion) for a patient, (2) creating a veriﬁcation plan (VerPlan) of
the previously created treatment plan, (3) performing mea-
surements of VerPlan using EPID matrix (collecting ﬂuence
maps and DynaLog ﬁles for every treatment ﬁeld or arc), (4)
dose distribution reconstruction (DDcon software), based on
actual leaf movements (previously collected DynaLog ﬁles), (5)
crating a veriﬁcation plan from the reconstructed one (VerRec)
to gain access to the reconstructed ﬂuence maps, (6) exporting
the measured ﬂuence maps from VerPlan veriﬁcation plan and
importing them to VerRec veriﬁcation plan, (7) comparison of
the reconstructed and measured ﬂuence maps.
Measuring ﬂuence maps using EPID matirx is one of the
standard QA methods in radiotherapy.13 In-phantom mea-
surements are obtained before the ﬁrst treatment session. The
aim of this method is to compare the calculated (theoretical)
ﬂuence maps with the measured (actual) ones. To prepare a
special QA plan for veriﬁcations, the “Create Veriﬁcation Plan”
option in TPS-Eclipse must be used. Evaluation of the the-
oretical and measured ﬂuence maps comparison is positive
when the gamma index is less than one in 95% of the analyzed
points of the treatment ﬁeld. All analyses are made using the
‘Portal Dosimetry’ application. If the evaluation result is nega-
tive, the measurement has to be repeated. If re-measurement
is not satisfactory, the plan has to be re-optimized and
the veriﬁcation procedure repeated. This procedure is time
tributions. DVHs show that the dose distributions for PTV
 the margin of calculation error.
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 (left
ion wFig. 5 – Evaluation of the measured (right side) and planned
Maximum gamma  index for that ﬁeld was 6.74. The evaluat
consuming and sometimes leads to a delay or interruption of
the treatment. Therefore, the reconstruction procedure, based
on actual leaf positions, might present an attractive, less time-
consuming solution. After the calculations are completed, the
real 3D dose distribution is compared with the theoretical one
using DVH’s or RPI index. If the evaluation meets our expecta-
tions, then treatment can be started.
To assess the feasibility of the proposed method, dose
reconstructions were performed for the following four cases.
The ﬁrst case involved the reconstruction of VMAT  treat-
ment plan for all treatment fractions. The treatment plan was
prepared for a prostate cancer patient and it consisted of one
360-degree arc. The total dose was 76 Gy, delivered in 38 2-Gy
fractions.
The second case involved the reconstruction of head&neck
IMRT  veriﬁcation treatment plan. The measurements were
performed before the treatment using EPID matrix.
The third case involved dose reconstruction in breast can-
cer. It was planned to deliver 50 Gy in 2-Gy fractions for PTV
(Planning Treatment Volume), 60 Gy (+10 Gy) for PTV-boost and
60 Gy in axillary and supraclavicular lymph nodes. The treat-
ment was planned for the IMRT  technique. To verify the quality
of the treatment plan, EPID matrix was used. The measure-
ments were performed before treatment.
The fourth case involved an interrupted VMAT treatment
plan consisting of one 340-degree arc. The treatment volume
was the prostate and the fraction dose was 2 Gy (441 MU). A
complementary treatment plan for a missing arc was prepared
using: DynaLog ﬁles for the incomplete arc, theoretical RTplan
from TPS and DDcon software.
Fig. 6 – Maximum dose in the reconstructed dose distribution (le
side). DVH shows the differences between the planned and recon side) ﬂuence maps comparison for one treatment ﬁeld.
as negative.
The statistical analyses were based on reconstructed and
theoretical treatment plans DVHs exported from the TPS. All
analyses were made using STATISTICA v.10 software. For all
analyses, non-parametric U Mann–Whitney test for two inde-
pendent samples with p = 0.05 was used.
4.  Results  and  discussion
The ﬁrst case: dose reconstruction for all executed treatment
fractions of VMAT treatment plan. Fig. 2 shows the theoreti-
cal and reconstructed (executed) dose distributions and DVH
graphs for PTV, the rectum, and bladder structures. Calcu-
lated RPI index values for the theoretical and reconstructed
dose distributions were 0.13415 and 0.13275, respectively. It
means that the difference between the two plans was not sig-
niﬁcant. The theoretical and reconstructed differential DVHs
were compared. Statistical analysis showed that there were
no statistically signiﬁcant differences (p = 0.910) between the
theoretical and reconstructed dose distributions.
The second case: reconstruction based on actual leave
motion of head&neck IMRT  veriﬁcation treatment plan.
Measured and calculated ﬂuence maps were compared
using “Portal dosimetry” application (Fig. 3). Treatment can
be started only when the evaluation of ﬂuence maps com-
parison is positive. In the analyzed example, the evaluation of
the measured and calculated ﬂuence maps comparison was
negative for 2 of 7 treatment ﬁelds. In this case, dose recon-
struction based on actual leaf positions was made. Fig. 4 shows
that the planned and reconstructed dose distributions were
ft side) is 4.37 Gy greater than that in the planned one (right
structed dose distributions for PTV (upper clavicle region).
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Fig. 7 – The reconstructed dose distribution for the interrupted arc of 297.8◦ (A) and the complementary arc of 42.2◦ (B). For
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aoth cases, the dose distributions are shown in lateral, front
onsistent within the calculation error of 1.5%. The maximal
lanned and reconstructed doses for PTV were 5.079 Gy and
.066 Gy, respectively. The planned total dose in the isocenter
as 4.8 Gy, delivered in three 1.6-Gy fractions. Considering the
ose distributions for PTV, the spinal canal and brainstem RPI
ndex for the planned and reconstructed dose distribution was
.77153 and 0.77149, respectively, indicating no signiﬁcant dif-
erences between both treatment plans. The theoretical and
econstructed differential DVHs were also compared. Statis-
ical analysis showed no statistically signiﬁcant differences
p = 0.975) between the theoretical and reconstructed dose dis-
ributions.
The third case: dose reconstruction in breast cancer. The
reatment was planned for the IMRT  technique. To verify the
uality of the treatment plan, EPID matrix was used. The mea-
urements were performed before treatment. The evaluation
f the measured and calculated ﬂuence maps comparison was
egative for 3 of 7 treatment ﬁelds. Fig. 5 shows the measured
nd planned ﬂuence maps for one of the treatment ﬁelds. As
ne can see, there are a few large point differences between
he planned and measured ﬂuence maps. The maximum
amma index for that ﬁeld was 6.74. According to the rou-
ine approach, this treatment plan should be measured once
ig. 8 – Comparison of the planned dose distribution (A) with the
nd missing arc (B).d sagittal slices.
again. The proposed dose distribution reconstruction method,
based on actual leaf movement, allows checking whether the
differences visible on the ﬂuence maps comparison have an
inﬂuence on the dose distribution.
Fig. 6 shows the planned and reconstructed dose dis-
tributions. As one can see, the maximum dose for PTV
(upper clavicle region) in the reconstructed dose distribution
is 4.37 Gy greater than that in the planned one.
This result indicated that, because of big differences
between the planned and reconstructed dose distributions for
PTV volume, another veriﬁcation measurement was unneces-
sary. Statistical analysis showed that there was a statistically
signiﬁcant (p = 0.015) difference between the planned and
reconstructed dose distributions for PTV (upper clavicle
region) volume. Therefore, the treatment plan had to be recon-
structed.
Fourth case: dose reconstruction of interrupted fraction in
the VMAT treatment technique. The treatment plan consisted
of one 340-degree arc. During one of the treatment sessions,
◦after 297.8 (381 from 441 MUs), an error occurred and the
beam was off. There were some problems with MLC  equip-
ment and treatment could not be continued. Fig. 7 shows
the reconstructed dose distribution for the interrupted arc
 planned sum of reconstructed combination of interrupted
426  reports of practical oncology and radiotherapy 1 9 ( 2 0 1 4 ) 420–427
Fig. 9 – Comparison of the measured (right side) and reconstructed (left side) ﬂuence maps. Gamma  index (3%, 2 mm)  was
nt ﬁe
rless than one in 99.6% of the analyzed points of the treatme
(reconstruction based on actual leaf motion) and the dose dis-
tribution for the complementary arc (42.2 degrees arc, 60 MU).
Sum of the interrupted (delivered) and missing arc was
compared with the original (theoretical) full arc. Comparison
of both dose distributions is shown in Fig. 8. Reconstruction
of the dose distribution for the interrupted arc allowed to
calculate the delivered dose of 1.628 Gy. To receive the total
fraction dose of 2 Gy, 0.372 Gy was missing. This information
was crucial for the treatment planning and treatment deliv-
ery. The maximum planned and reconstructed dose for CTV
was 2.134 Gy and 2.136 Gy, respectively. The difference was
acceptably small.
Statistical analysis showed no statistically signiﬁcant dif-
ference (p = 0.893) between the planned and reconstructed
dose distributions.
According to the presented veriﬁcation method (see Sec-
tion 3), the reconstructed and measured ﬂuence maps were
compared for all ﬁelds and arcs in the ﬁrst three cases. For
the fourth one, there was no measured ﬂuence map  during
the interrupted session, so analyses were not possible. Fig. 9
shows an example of the ﬂuence map  comparison for one of
the analyzed ﬁelds. As one can see, there is very good agree-
ment between the reconstructed and measured ﬂuence maps.
M.  Dinesh Kumar8 presented a similar reconstruction
method, but with the use of a phantom and for the IMRT tech-
nique only. New algorithm, developed in our center, allows
to reconstruct not only IMRT  but also the VMAT  technique,
including interrupted arcs. All analyses and calculations
showed that the presented reconstruction method might be
very useful for evaluation of the treatment plan delivery (IMRT
and VMAT). It can also be applied to evaluate the inﬂuence
of discrepancies between the planned and actual MLC leaf
motion on the dose distribution. This very comfortable ver-
iﬁcation method can be used before, during or after treatment
to evaluate the whole treatment process by reconstructing any
treatment fraction. In addition, it is extremely useful in situa-
tions when delivery of the dose was interrupted. This software
provides means not only to reconstruct an interrupted VMAT
treatment, but also to generate a complementary treatment
plan.A separate issue in dose distribution reconstruction
is the CT (Computed Tomography) scans used for the
reconstruction.14,15 In the presented method, the reconstruc-
tion is performed using CT scans made before treatment,ld.
so no anatomical changes are considered. The next step to
improve this reconstruction method will require inclusion of
those changes into the calculation process, using CBCT (Cone
Beam Computed Tomography) scans that are obtained during
the treatment session. However, the quality of CBCT images
is still insufﬁcient, which affects the calculated dose distri-
butions and leads to signiﬁcant inaccuracy. Our experience is
consistent with J. Qian ﬁndings.16 As the quality of CBCT scans
continuously improves, it might be possible to use them for
this purpose in the foreseeable future.
5.  Conclusions
Using four different scenarios, we showed that our dose dis-
tribution reconstruction algorithm, based on actual MLC  leaf
motion, presents a very useful tool for radiotherapy QA proce-
dures. It provides means to verify 3D dose distribution in the
patient and allows to evaluate the inﬂuence of actual MLC leaf
motion on the dose distribution. It should be emphasized that
one have to remember about the dose and MLC  calibrations to
prepare linac for IMRT and VMAT deliveries.
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